You are here > News and publications

News and publications

Promethera Biosciences shortlisted for essenscia Innovation Award 2012


Promethera Biosciences is pleased to announce that it was one of the top 5 finalists, amongst 36 Belgian Chemistry and Biotech companies candidates, that competed for the essenscia Innovation Award 2012. As a multisectoral umbrella organization, essenscia represents the numerous sectors of activities in the fields of chemistry and life sciences. It includes nearly 800 companies representing more than 95% of the overall turnover in the sector.  The structure of essenscia is modeled on the reality of the Belgian institutions, with federal, regional and community areas of competence. The finalists were selected based on a description of the innovation, its unique character and its proof of concept, its contribution towards sustainable development, its intellectual property strategy and its contribution to the Belgian economy (investment, employment, know-how).



PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
B-1435 Mont-Saint-Guibert
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01

News and Public release

CEO John Tchelingerian to Discuss Strategic Collobarations and Partnering Strategies in Cell Therapy at ARM’s Advanced Therapies Summit
Collaboration to Drive Development and Commercialization of Promethera’s Cell-based Liver-Focused Therapeutics Portfolio in Korea